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A Statement on Ethics From the HEART Group
ver the past several years, the editors of leading international cardiovascular journals have met to form the HEART group
nd to discuss areas of growing, common interest. Recently, the HEART group has developed a document that addresses
eneral ethical principles in the conduct of the scientific process with which all of the editors concur. Published essentially
imultaneously in all of the participating journals, including this journal, this document presents the ethical tenets accepted
y all of the undersigned editors that will (continue to) guide their decisions in the editorial process.
These are the general principles on which the HEARTGroup is based and by which we, as a group, abide; however, please
ote that individual journal members and their respective societies may have their own rules and regulations that supersede
doi:10.1016/j.jacc.2008.01.001he guidelines of the HEART Group.
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he purpose of this is to ensure transparency and honesty in
he scientific process that promotes ethical conduct in the
erformance and publication of research.
The following will be considered as parts of this process:
a. Disclosure of potential conflicts of interest for all
involved in the performance of research and in the
evaluation and publication process of a manuscript.
Relevant relationships with commercial interests will
be defined in terms of levels and nature of support.
The nature of support will be listed as grants, sup-
plies/equipment, type of employment, or personal
income. Equity and royalty interests should be stated
as well as any fiduciary relationship with the sponsor.
b. Establish thorough review processes particularly alert
to discovering scientific fraud and data falsification,
redundant or duplicate publication, and plagiarism,
and to adopt a uniform standard of dealing with
authors guilty of fraudulent practices.
c. Maintain confidentiality and embargos where appro-
priate.
d. Create uniform criteria to establish authorship. To
qualify for authorship, individuals must have made
substantial contributions to the intellectual content of
the paper in at least 1 of the following areas: conceivedand designed the research; acquired the data; analyzed
and interpreted the data; performed statistical analy-
sis; handled funding and supervision; drafted the
manuscript; or made critical revision of the manu-
script for important intellectual content.
Authors must give final approval of the version to be
submitted and any revised version to be published. For
multicenter trials, individuals who accept direct re-
sponsibility for the manuscript should fully meet the
criteria for authorship previously defined; contributors
not meeting these criteria should be acknowledged.
e. Note avoidance of false claims of ownership and
priority, by attention to previous publications.
f. Establish avoidance of excessive claims of benefits of a
product/technique in the publication as well as with
news media.
g. Note compliance with institutional review board
requirements and, when appropriate, approved labo-
ratory procedures for animal research, and that the
research conforms to the ethical standards of the
Declaration of Helsinki, the Geneva Declaration, the
Belmont Report, and Good Clinical Practices from
the FDA, and the submission conforms to the Inter-
national Committee of Medical Journal Editors (IC-
MJE) “Uniform Requirements for Manuscripts Sub-
mitted to Biomedical Journals: Writing and Editing
for Biomedical Publication” (www.ICMJE.org).
